Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biologic Agents”

Showing 20 of 0 results

Not applicableStudy completedNCT06299631
What this trial is testing

Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease

Who this might be right for
Crohn's Disease
University Hospital, Montpellier 133
Not applicableStudy completedNCT01870908
What this trial is testing

Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 664
Not applicableEnded earlyNCT01449175
What this trial is testing

A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema

Who this might be right for
Chronic Pulmonary Obstructive DiseaseEmphysema
Aeris Therapeutics 54
Testing effectiveness (Phase 2)WithdrawnNCT01200264
What this trial is testing

Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy

Who this might be right for
Chronic Plaque Psoriasis
Duke University
Not applicableStudy completedNCT01823107
What this trial is testing

Feasibility Study of Meso BioMatrix Device for Breast Reconstruction

Who this might be right for
Breast Cancer
Kensey Nash Corporation 25
Large-scale testing (Phase 3)Study completedNCT01077362
What this trial is testing

The Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 312
Not applicableUnknownNCT00925249
What this trial is testing

Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy

Who this might be right for
Rheumatoid ArthritisTuberculosis
Walter Reed Army Medical Center 90
Large-scale testing (Phase 3)WithdrawnNCT00716053
What this trial is testing

Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

Who this might be right for
Advanced Upper Lobe Predominant Emphysema
Aeris Therapeutics 225
Large-scale testing (Phase 3)Study completedNCT01015547
What this trial is testing

Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Helsinki University Central Hospital 60
Not applicableUnknownNCT05805449
What this trial is testing

BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma

Who this might be right for
Anal Fistula
The University of Texas Health Science Center, Houston 250
Not applicableStudy completedNCT01405430
What this trial is testing

Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab

Who this might be right for
Colorectal CancerMetastasis
Centre Leon Berard 63
Testing effectiveness (Phase 2)WithdrawnNCT03393481
What this trial is testing

Prevention of Thromboembolic Events in Total Knee Replacement Patients

Who this might be right for
Thrombotic Disorders
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT04717466
What this trial is testing

Brain Changes in Psoriasis After Secukinumab Treatment

Who this might be right for
PsoriasisHealthy
University of Miami 20
Testing effectiveness (Phase 2)UnknownNCT06114329
What this trial is testing

Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease

Who this might be right for
Fabry Disease
AceLink Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT01683396
What this trial is testing

Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand

Who this might be right for
Osteoarthritis
XOMA (US) LLC 87
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Testing effectiveness (Phase 2)Study completedNCT00206505
What this trial is testing

Neoadjuvant Taxotere

Who this might be right for
Breast Cancer
Baylor Breast Care Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06477653
What this trial is testing

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Who this might be right for
Hypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT02573571
What this trial is testing

Personalized Needs in Clostridium Difficile Infections

Who this might be right for
Biologic MarkersClinical Markers
University of Athens 150
Early research (Phase 1)Ended earlyNCT01529307
What this trial is testing

First in Human Trial of TAS266 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 6
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation